Average Insider

Where insiders trade, we follow

$EXOZ
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
Healthcare
Sector
Biotechnology
Industry
Michael Heltzen
CEO
31
Employees
$6.79
Current Price
$80.94M
Market Cap
52W Low$4.35
Current$6.7917.4% above low, 82.6% below high
52W High$18.40

Insider Activity Statistics

Aggregated buying and selling activity by time period
PeriodTypeInsidersTransactionsValueSharesBuy/Sell Ratio
1 weekBuys00---
Sells00--
2 weeksBuys00---
Sells00--
1 monthBuys15$6,405.17855All Buys
Sells00--
2 monthsBuys15$6,405.17855All Buys
Sells00--
3 monthsBuys15$6,405.17855All Buys
Sells00--
See activity going back 12 months โ€” create a free account

Insider Transactions

Recent purchases and sales by company insiders
DateInsiderTypeSharesPriceValueActions
Aug 26, 2026
Heltzen Michael
Chief Executive Officer
Purchase250$7.60$1,900.00View Details
Aug 25, 2026
Heltzen Michael
Chief Executive Officer
Purchase250$7.52$1,880.00View Details
Aug 26, 2026
Heltzen Michael
Chief Executive Officer
Purchase251$7.35$1,844.85View Details
Aug 26, 2026
Heltzen Michael
Chief Executive Officer
Purchase4$7.58$30.32View Details
Aug 25, 2026
Heltzen Michael
Chief Executive Officer
Purchase100$7.50$750.00View Details
2 more transactions available โ€” create a free account to see 12 months of history

Upcoming Earnings

Scheduled earnings reports
No upcoming earnings scheduled

Past Earnings

Historical earnings results
No earnings data in the last 3 months. Sign up free to see 12 months of history.
Version: v26.7.3